February 24, 2025 - 23:16

GigaCloud Technology has officially scheduled the release of its fourth-quarter and full-year earnings for March 3. This announcement is highly anticipated by investors and industry analysts, as it will provide insight into the company's financial performance and strategic direction.
Following the earnings release, GigaCloud will host an investor conference call at 5:30 PM ET, where company executives will discuss the results in detail and address questions from investors. Participation in the call requires pre-registration, ensuring that interested parties have the opportunity to engage directly with the company's leadership.
As a key player in the B2B tech sector, GigaCloud's financial results are closely monitored, and this upcoming release is expected to shed light on the company's growth trajectory and market positioning. Investors are keen to understand how GigaCloud has navigated the challenges of the past year and what strategies it has in place for future success.
December 8, 2025 - 19:45
Microchip Technology Set to Showcase Innovations at Barclays Global Technology ConferenceCHANDLER, Ariz., Dec. 08, 2025 – Microchip Technology Incorporated, a prominent player in the embedded control solutions sector, has announced its participation in the Barclays 23rd Annual Global...
December 8, 2025 - 04:24
Apple Faces Leadership Crisis as Chip Chief Considers DepartureApple is grappling with a significant leadership challenge as Johny Srouji, the company`s influential chip chief, contemplates stepping down. Srouji, who has played a pivotal role in establishing...
December 7, 2025 - 23:39
Evaluating Marvell Technology: A Potential Bargain or Overinflated?If you are wondering whether Marvell Technology, currently priced around $98.91, is a bargain or a bubble, you are not alone. This stock has emerged as a focal point for growth-focused investors....
December 7, 2025 - 04:40
Innovations in Technology Enhance Safety and Accessibility of Blood Cancer TreatmentsRecent developments in technology are significantly improving the safety and accessibility of therapies for blood cancer, as showcased in four clinical trials presented at the 67th American Society...